ORAGENICS, INC. Notes Issued
ORAGENICS, INC. (OGEN) reported Notes Issued of $2.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-02-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesIssued1 · last filed 2018-02-16
- ORAGENICS, INC. notes issued for the quarter ending 2016-12-31 was $0.00.
- ORAGENICS, INC. notes issued for the quarter ending 2016-09-30 was $1.55M.
- ORAGENICS, INC. notes issued for the quarter ending 2012-09-30 was $84.88K, a 9.17% increase year-over-year.
- ORAGENICS, INC. notes issued for the quarter ending 2012-06-30 was $0.00.
- ORAGENICS, INC. notes issued for fiscal 2016 was $2.00M.
| Period end | Notes Issued 3 month | Notes Issued 6 month | Notes Issued 9 month | Notes Issued 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $1.55M derived: sum of 2 quarters · filed 2018-02-16 | $2.00M 10-K · filed 2018-02-16 | |
| 2016-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $2.00M 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $450.00K 10-Q · filed 2017-08-14 | |||
| 2012-09-30 | $84.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $84.88K derived: sum of 2 quarters · filed 2012-11-14 | $134.91K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $50.04K 10-Q · filed 2012-08-10 | ||
| 2012-03-31 | $50.04K 10-Q · filed 2012-05-15 | |||
| 2011-09-30 | $77.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $77.75K derived: sum of 2 quarters · filed 2012-11-14 | $126.74K 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $48.99K 10-Q · filed 2012-08-10 | ||
| 2011-03-31 | $48.99K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |